Weekly Recap: Plague Concern, AI Prescribing in Utah, and FTC Pricing Warning
This weekly medical news roundup covers a Russian laboratory worker's death that raised plague concerns. It also notes Utah's move to allow artificial intelligence to write first-time prescriptions. Additionally, the FTC warned 24 health systems about concealed pricing.
This week's roundup combines three medical developments. A Russian laboratory employee's death renewed concern about plague. Utah has taken a step toward allowing artificial intelligence to write first-time prescriptions. The Federal Trade Commission warned 24 health systems about concealed pricing. Together, these items reflect ongoing attention to infectious disease monitoring, automation in clinical care, and transparency in medical costs.
The effects may vary by group. Patients could face changes in how first prescriptions are reviewed and how medical prices are disclosed. Clinicians and health systems may need to adapt oversight and billing practices. Public health officials may remain alert to rare infectious disease cases. Consumers may benefit from clearer costs, though enforcement and implementation could take time.